The ALK inhibitor ASP3026 eradicates NPM-ALK(+) T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model

por George, Suraj Konnath, Vishwamitra, Deeksha, Manshouri, Roxsan, Shi, Ping, Amin, Hesham M.
Publicado 2014

SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein()

por Vishwamitra, Deeksha, Curry, Choladda V., Shi, Ping, Alkan, Serhan, Amin, Hesham M.
Publicado 2015

Type I insulin-like growth factor receptor signaling in hematological malignancies

por Vishwamitra, Deeksha, George, Suraj Konnath, Shi, Ping, Kaseb, Ahmed O., Amin, Hesham M.
Publicado 2016

The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK(+) T-cell lymphoma

por Vishwamitra, Deeksha, Curry, Choladda V, Alkan, Serhan, Song, Yao-Hua, Gallick, Gary E, Kaseb, Ahmed O, Shi, Ping, Amin, Hesham M
Publicado 2015

S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY

por Offner, Fritz, Decaux, Olivier, Hulin, Cyrille, Anguille, Sébastien, Sophie Michallet, Anne, Costa, Luciano, Touzeau, Cyrille, Boyd, Kevin, Vishwamitra, Deeksha, Guo, Yue, Niu, Zhuolu, Larsen, Julie, Chen, Lingling, Banerjee, Arnob, Goldberg, Jenna, Matous, Jeffrey
Publicado 2023

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab

por Falchook, Gerald S, Wheler, Jennifer J, Naing, Aung, Jackson, Edward F, Janku, Filip, Hong, David, Ng, Chaan S, Tannir, Nizar M, Lawhorn, Kristie N, Huang, Mei, Angelo, Laura S, Vishwamitra, Deeksha, Hess, Kenneth, Howard, Adrienne N, Parkhurst, Kristin L, Amin, Hesham M, Kurzrock, Razelle
Publicado 2014

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma

por Kaseb, Ahmed O., Haque, Abedul, Vishwamitra, Deeksha, Hassan, Manal M., Xiao, Lianchun, George, Bhawana, Sahu, Vishal, Mohamed, Yehia I., Carmagnani Pestana, Roberto, Lombardo, Jamie Lynne, Avritscher, Rony, Yao, James C., Wolff, Robert A., Rashid, Asif, Morris, Jeffrey S., Amin, Hesham M.
Publicado 2022

P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY

por Tan, Carlyn, Searle, Emma, Anguille, Sébastien, Bhutani, Manisha, Biran, Noa, Boyd, Kevin, Cowan, Andrew, Matous, Jeffrey, Perrot, Aurore, Berdeja, Jesus, Janowski, Wojciech, Popat, Rakesh, Quach, Hang, Schroeder, Mark, Wong, Sandy W, Vishwamitra, Deeksha, Guo, Yue, Niu, Zhuolu, Larsen, Julie, Chen, Lingling, Banerjee, Arnob, Touzeau, Cyrille
Publicado 2023

P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MON...

por Rasche, Leo, Schinke, Carolina, Chari, Ajai, Lipe, Brea C., Lavi, Noa, Rodríguez-Otero, Paula, Vishwamitra, Deeksha, Skerget, Sheri, Verona, Raluca, MA, Xuewen, Khedkar, Sheetal, Hilder, Brandi, Masterson, Tara, Campagna, Michela, Renaud, Thomas, Tolbert, Jaszianne, Heuck, Christoph, Smit, Damiette, van de Donk, Niels W.C.J.
Publicado 2023

S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

por Touzeau, Cyrille, Schinke, Carolina, Minnema, Monique, van de Donk, Niels W.C.J., Rodríguez-Otero, Paula, Mateos, Maria-Victoria, Rasche, Leo, Ye, Jing Christine, Vishwamitra, Deeksha, MA, Xuewen, Qin, Xiang, Campagna, Michela, Masterson, Tara, Hilder, Brandi, Tolbert, Jaszianne, Renaud, Thomas, Goldberg, Jenna, Heuck, Christoph, Chari, Ajai
Publicado 2023

Targeting BCL‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma

por Kaufman, Jonathan L., Gasparetto, Cristina, Schjesvold, Fredrik H., Moreau, Philippe, Touzeau, Cyrille, Facon, Thierry, Boise, Lawrence H., Jiang, Yanwen, Yang, Xiaoqing, Dunbar, Fengjiao, Vishwamitra, Deeksha, Unger, Stefanie, Macartney, Tammy, Pesko, John, Yu, Yao, Salem, Ahmed Hamed, Ross, Jeremy A., Hong, Wan‐Jen, Maciag, Paulo C., Pauff, James M., Kumar, Shaji
Publicado 2021

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers

por Amin, Hesham M., Morani, Ajaykumar C., Daw, Najat C., Lamhamedi-Cherradi, Salah-Eddine, Subbiah, Vivek, Menegaz, Brian A., Vishwamitra, Deeksha, Eskandari, Ghazaleh, George, Bhawana, Benjamin, Robert S., Patel, Shreyaskumar, Song, Juhee, Lazar, Alexander J., Wang, Wei-Lien, Kurzrock, Razelle, Pappo, Alberto, Anderson, Peter M., Schwartz, Gary K., Araujo, Dejka, Cuglievan, Branko, Ratan, Ravin, McCall, David, Mohiuddin, Sana, Livingston, John A., Molina, Eric R., Naing, Aung, Ludwig, Joseph A.
Publicado 2020